12.58
price down icon1.80%   -0.23
pre-market  Pre-mercato:  12.90   0.32   +2.54%
loading

Niagen Bioscience Inc Borsa (NAGE) Ultime notizie

pulisher
Jun 18, 2025

Niagen Bioscience (NASDAQ:NAGE) Shares Down 2.4%Should You Sell? - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Market Participants Recognise Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Revenues Pushing Shares 29% Higher - simplywall.st

Jun 17, 2025
pulisher
Jun 16, 2025

Niagen Bioscience (NASDAQ:NAGE) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

Jun 16, 2025
pulisher
Jun 14, 2025

Niagen Bioscience (NASDAQ:NAGE) Price Target Raised to $16.00 - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Niagen Bioscience (NASDAQ:NAGE) Downgraded to Buy Rating by Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Niagen Bioscience (NASDAQ:NAGE) Sets New 12-Month High After Analyst Upgrade - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

Niagen Bioscience to Participate in the BIO 2025 International C - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Niagen Bioscience to Participate in the BIO 2025 International Convention - Business Wire

Jun 11, 2025
pulisher
Jun 11, 2025

Niagen Bioscience: High Conviction, High Expectations (NASDAQ:NAGE) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

Canaccord Genuity Group Issues Positive Forecast for Niagen Bioscience (NASDAQ:NAGE) Stock Price - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Niagen Bioscience (NAGE): Analyst Reaffirms Buy Rating and Incre - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Niagen Bioscience (NAGE) Gains Boost with Positive Clinical Resu - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Niagen study shows promise for Werner Syndrome treatment By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder - Business Wire

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highl - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen Bioscience stock rises following positive clinical study By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen Bioscience stock rises following positive clinical study - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen study shows promise for Werner Syndrome treatment - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up After Analyst Upgrade - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Niagen Bioscience (NASDAQ:NAGE) Given New $23.00 Price Target at Roth Capital - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

Niagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up on Analyst Upgrade - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Analyst Upgrade - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Roth Capital Reiterates “Buy” Rating for Niagen Bioscience (NASDAQ:NAGE) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Niagen Bioscience (NASDAQ:NAGE) Reaches New 12-Month HighWhat's Next? - MarketBeat

Jun 07, 2025
pulisher
Jun 06, 2025

Niagen Bioscience (NAGE) Target Price Raised to $23 by Roth Capi - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Niagen Bioscience (NAGE) Receives Price Target Boost from Roth Capital | NAGE Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

What 4 Analyst Ratings Have To Say About Niagen Bioscience - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Niagen Bioscience (NAGE) Target Price Raised to $23 by Roth Capital | NAGE Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Niagen Bioscience (NASDAQ:NAGE) Trading 8.2% HigherShould You Buy? - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Niagen Bioscience Inc (NASDAQ:NAGE) Q1 2025 Earnings Call Transcript - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Niagen Bioscience to Present at Oppenheimer's 25th Annual Consum - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Niagen Bioscience to Present at Oppenheimer's 25th Annual Consumer Growth and E-Commerce Conference | NAGE Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference - Business Wire

Jun 04, 2025
pulisher
Jun 03, 2025

Niagen Bioscience (NASDAQ:NAGE) Reaches New 1-Year HighHere's What Happened - MarketBeat

Jun 03, 2025
pulisher
May 31, 2025

Niagen Bioscience (NASDAQ:NAGE) Now Covered by Canaccord Genuity Group - MarketBeat

May 31, 2025
pulisher
May 28, 2025

Niagen Bioscience (NASDAQ:NAGE) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World

May 28, 2025
pulisher
May 27, 2025

Canaccord Genuity Initiates Coverage of Niagen Bioscience (NAGE) with Buy Recommendation - Nasdaq

May 27, 2025
pulisher
May 27, 2025

Canaccord Genuity Initiates Niagen Bioscience at Buy With $13 Price Target - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Canaccord starts Niagen Bioscience at Buy on ‘unique opportunity’ - TipRanks

May 27, 2025
pulisher
May 27, 2025

Niagen Bioscience (NAGE) Receives Positive Outlook with $13 Pric - GuruFocus

May 27, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):